|
Market Cap (2-Jul) $363,897,504 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 29 May 2023, 8:20. The announcement is marked as price sensitive, and is 2 page(s) in length and 217.16kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.376% short sold according to ASIC data. It was ranked the 353rd most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Charles River Laboratories to run IMP761 Toxicology Study | 29 May 2023, 8:20 |
| Publication of Abstracts for ASCO 2023 Annual Meeting | 26 May 2023, 8:24 |
| 1st patient dosed in AIPAC-003 ph2/3 breast cancer trial | 25 May 2023, 8:19 |
| Promising New Data in 1st line NSCLC from INSIGHT-003 Trial | 24 May 2023, 9:01 |
You must be logged in to post a reply.
